Profound Medical Corp. Share Price & Technical Analysis
PROF · $6.67 (-0.60%)
Healthcare / Medical Devices
$6.67
-0.60%
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedba…
Price chart
Seasonality
Jun has 3 positive and 1 negative years (last 5 years shown)
0% return in Jun, 11% avg return in past 3 year Jun month.
-14% return in 2026, 5% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | 1% | -13% | 3% | 0% | 0% | – | – | – | – | – | – | -14% |
| 25 | -16% | 11% | -16% | -14% | 8% | 13% | -5% | -20% | 9% | 24% | 8% | 23% | 28% |
| 24 | 3% | 5% | -8% | -11% | -3% | 14% | 25% | -14% | -12% | -9% | 9% | -9% | -9% |
| 23 | 12% | 7% | -30% | 23% | 3% | 7% | -13% | -21% | 13% | -16% | 28% | -20% | -5% |
| 22 | -11% | 8% | -16% | -20% | 27% | -22% | 18% | -20% | -41% | 0% | 14% | 118% | 57% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$245.64M
P/E ratio
—
52W high
$8.95
52W low
$3.76
Volume
24,800
Beta
0.52
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
Unitedhealth Group Inc
₹7,059
Frequently asked questions
- What is Profound Medical Corp. share price today?
- Profound Medical Corp. (PROF) last traded around $6.67 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PROF have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PROF. Download the app for real-time alerts.
- How can I analyze Profound Medical Corp. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.